Toxicokinetics & Pharmacokinetics

The study of toxicokinetics and pharmacokinetics plays a crucial role in drug development and safety assessment. Creative Bioarray offers a wide range of related resources, which allow researchers to evaluate the pharmacokinetic properties of drugs and assess their potential toxicity.

Troubleshooting Common Issues in Drug Toxicity Testing

Tag: Drug Toxicity

Details: A practical guide to troubleshooting common issues in drug toxicity testing, including assay variability, model limitations, and drug exposure challenges in preclinical studies.

The 8 Types of Drug Toxicity Every Researcher Must Know

Tag: Drug Toxicity

Details: Discover key drug toxicity types and modern preclinical approaches to evaluate liver, kidney, heart, and other organ risks for safer drug development.

Preclinical Workflow for Drug Toxicity Testing

Tag: Preclinical Toxicology

Details: A comprehensive overview of the preclinical workflow for drug toxicity testing, covering in vitro screening, in vivo toxicology studies, safety pharmacology, and GLP-compliant safety evaluation before clinical trials.

How Can You Optimize Drug Toxicity Assessment?

Tag: Drug Toxicity

Details: Learn how strategic preclinical toxicity design and CRO expertise help identify risks, improve safety, and accelerate drug development success.

2D vs 3D Cell Culture Models: Which Is Best for Drug Toxicity Testing?

Tag: Drug Toxicity

Details: A comparative overview of 2D and 3D cell culture models for drug toxicity assessment, highlighting their applications, advantages, and roles in improving preclinical safety prediction.

The 8 Costliest Mistakes in Preclinical CYP Phenotyping

Tag: Drug Metabolism, CYP Phenotyping

Details: A guide to the 8 common CYP phenotyping mistakes and how to fix them, improving ADME data, predicting DDIs, and accelerating preclinical drug development.

Reaction Phenotyping vs. Metabolic Stability

Tag: Drug Metabolism

Details: A concise comparison of Metabolic Stability and Reaction Phenotyping, highlighting their distinct purposes in drug development and providing clear guidance on when to apply each assay.

How to Interpret CYP Phenotyping Data

Tag: Drug Metabolism, CYP Phenotyping

Details: Step-by-step guidance on interpreting CYP phenotyping results to support DDI risk assessment and development decisions.

A Complete Guide to CYP Reaction Phenotyping in 2026

Tag: Drug Metabolism, CYP Phenotyping

Details: A practical guide explaining the purpose, methods, and application of CYP reaction phenotyping in drug development for effective DDI risk assessment.

6 Easy Steps to Get Your In Vitro ADME Done

Tag: ADME

Details: A practical 6-step workflow for planning, executing, and interpreting in vitro ADME assays to support early drug discovery and informed compound selection.

When Should You Introduce ADME Tox Testing in Drug Development?

Tag: ADME

Details: A stage-based ADME-Tox strategy highlighting key risk signals and integrated safety, PK, and potency insights to support better development decisions.

Top 5 Pitfalls in In Vitro ADME Assays and How to Avoid Them

Tag: ADME

Details: In vitro ADME assays are key to early drug discovery-but poor design can mislead project decisions. Learn the five critical pitfalls, from model selection to concentration choices, and see how to turn your ADME data into actionable insights.

In Vitro ADME vs In Vivo ADME

Tag: ADME

Details: A concise comparison of in vitro and in vivo ADME studies, explaining their respective roles, limitations, and how to use them together to support confident drug development decisions.

How to Choose the Right In Vitro ADME Assays for Small-Molecule Drugs

Tag: ADME

Details: A practical guide to selecting the right in vitro ADME assays for small-molecule drug discovery, aligned with development stage, physicochemical properties, and translational decision-making.

What Is Genotoxicity in Pharmacology? Mechanisms and Sources

Tag: Genotoxicity

Details: Explore the molecular mechanisms behind genotoxicity and understand why assessing genetic risk is essential for safe drug discovery.

How Genotoxicity Testing Guides Safer Drug Development

Tag: Genotoxicity

Details: A practical overview of genotoxicity assays, regulatory considerations, and data interpretation for researchers and drug developers.

From Cells to Systems: Modern Approaches to Disease Modeling

Tag: Disease model

Details: An overview of disease modeling strategies, applications, and major challenges in preclinical research.

What Are the Best Methods to Test Cardiotoxicity?

Tag: Cardiotoxicity

Details: Explore the most widely used cardiotoxicity testing methods—including in vitro assays, in vivo models, and advanced imaging.

Why Cardiotoxicity Matters in R&D?

Tag: Cardiotoxicity

Details: Discover what cardiotoxicity is, the key biological mechanisms behind it, and why evaluating cardiotoxic risks is essential in modern drug development and safety testing.

Key Considerations in Toxicokinetic

Tag: Toxicokinetic

Details: This article briefly explores toxicokinetics studies from aspects such as dose selection, matrix selection, choice of animal models, and sample collection

First Previous Next Last

For research use only. Not for any other purpose.